MedPath

Clinical study on optimal strategy for treatment of Non-active Graves ophthalmopathy

Phase 1
Conditions
Graves ophthalmopathy
Registration Number
ITMCTR2000003668
Lead Sponsor
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Typical ocular symptoms;
2. Protrusion degree & GT;18mm(including unilateral protruding eye);
3. Inactive protrusion is defined as the clinical scoring standard recommended by the 2008 Chinese Guidelines for the Diagnosis and treatment of thyroid diseases;
4. Refuse operation patients;
5. Patients with Graves' disease and normal serum thyroid hormone levels (FT3 and FT4) for at least two months;
6. Informed consent, willing to receive treatment and with good predictive compliance, age 18-70 years old;
7. TCM syndrome differentiation indicates deficiency of Yang qi and blockage of phlegm and blood stasis.

Exclusion Criteria

1. Shortness of eyes caused by other causes: case of shortness of eyes, orbital inflammatory pseudotumor, carotid cavernous fistula or dural cavernous sinus short circuit, extraocular muscle lymphoid tumor, primary orbital tumor, eye metastasis tumor, intracranial tumor and other diseases.
2. Clinical score of protruding eye activity >= 3.
3. Psychopaths.
4. Patients with severe primary and secondary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, and with a tendency of hyperthyroidism crisis.
5. Women who are pregnant or breastfeeding.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
proptosis;
Secondary Outcome Measures
NameTimeMethod
Orbital computed tomography;vision;TCM syndrome score;
© Copyright 2025. All Rights Reserved by MedPath